Medical News

RSS

Archimedes publishes FPNS clinical study results in Pain journal

Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).

5 Oct 2010

IRIDEX announces commercial availability of extended EndoProbe laser delivery device family in Japan

IRIDEX Corporation today announced approval and commercial availability in Japan for its extended family of EndoProbe laser delivery devices. The EndoProbe is an intraocular laser delivery device used during vitreoretinal surgery for the treatment of multiple disorders including: diabetic retinopathy, retinal detachments and vitreous hemorrhage. IRIDEX distributes products in Japan through their partner, TOMEY Corporation.

5 Oct 2010

HighPoint Solutions launches ICD-10 Appliance for healthcare systems

HighPoint Solutions announced today the launch of its ICD-10 Appliance, a master data solution that helps hospitals, healthcare systems, and payers with ICD-10 compliance. The ICD-10 Appliance employs master data management principles and tools to create a central business management layer with ICD-9/ICD-10 mappings, translations, and business rules that can be utilized by all applications.

5 Oct 2010

Preclinical data of Enzon's PEG-SN38 in pediatric neuroblastoma published in Clinical Cancer Research

Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.

5 Oct 2010

Caring.com introduces interactive Alzheimer’s resource for caregivers

Caring.com today launched Steps & Stages, the first-ever interactive guide, support system, and customized e-mail newsletter that delivers specific, stage-appropriate advice for those providing care for a loved one with Alzheimer's or another form of dementia.

5 Oct 2010

Majority of Canadians with asthma consider their disease 'well controlled'

A new survey, Asthma Insight and Management in Europe and Canada (EUCAN AIM), reveals that a majority of Canadians with asthma considered their disease "well controlled" at the time of the survey. However, in the year prior to the survey, more than half (52 per cent) required acute treatment for asthma, including seeing a doctor for worsening symptoms (45 per cent), unscheduled emergency room visits (28 per cent), and being hospitalized overnight (five per cent).

5 Oct 2010

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.

5 Oct 2010

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.

5 Oct 2010

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

The Belgian biotech company Galapagos has won the 2010 EUROPEAN BIOTECHNICA AWARD. Galapagos thus secures the lion's share of the prize money totalling 75,000 euros, which is offered every year in the competition staged by Deutsche Messe AG and its partners. The award celebrates innovative European companies from the biotechnology sector and the life sciences.

5 Oct 2010

ImmunoCellular Therapeutics to present ICT-107 clinical data at World Stem Cell Summit

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that the company's clinical data from ICT-107 will be featured in two oral sessions at the World Stem Cell Summit, which is being held October 4-6 in Detroit, MI.

5 Oct 2010

GE Healthcare launches first human cellular assay product

Geron Corporation today announced that GE Healthcare has launched the first human cellular assay product for use in drug discovery and toxicity screening, developed under a license and alliance agreement between the two companies.

5 Oct 2010

SpinalMotion announces completion of enrollment in Kineflex lumbar artificial disc study

SpinalMotion, Inc., developer of the investigational Kineflex® lumbar and Kineflex®|C cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach. The data from the study will be used to support regulatory submissions for international commercialization.

5 Oct 2010

Celgene announces pricing of senior unsecured notes

Celgene Corporation today announced the successful pricing of three series of senior unsecured notes for an aggregate principal amount of $1.25 billion.

5 Oct 2010

Medyssey Spine fourth-quarter 2010 sales increase 112%

Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.

5 Oct 2010

EUCODIS Bioscience, evocatal enter alliance to market industrial enzyme products

Industrial biotech companies EUCODIS Bioscience and evocatal today announced the formation of an alliance to jointly market the companies' industrial enzyme products, including alcohol dehydrogenases, lipases, and other enzymes.

5 Oct 2010

Ceremed's implantable polymer material receives Best New Technology for Spine Care award

Ceremed's patented implantable polymer material known as AOC won Orthopedics This Week's annual award for Best New Technology for Spine Care in 2010 in the Biomaterials category.

5 Oct 2010

FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Atazanavir Sulfate Capsules, 150 mg and 300 mg. This product will be eligible for purchase outside the U.S. in certain developing countries.

5 Oct 2010

Dr. Bessler joins Children's Hospital of Philadelphia

One of the world's leading experts in bone marrow failure and related blood disorders recently joined The Children's Hospital of Philadelphia. Hematology researcher Monica Bessler, M.D., Ph.D., arrived at the hospital this summer to establish a new program, the Pediatric and Adult Comprehensive Bone Marrow Failure Center.

5 Oct 2010

First Edition: October 5, 2010

Today's headlines include reports on the midterm elections and recent polls as well as the latest developments related to Medicaid expansion.

5 Oct 2010

Genzyme shareholders urged not to take action on unsolicited tender offer from Sanofi-Aventis

Genzyme Corp. said today that its board of directors urged shareholders to take no action on an unsolicited tender offer from Sanofi-Aventis to acquire all outstanding common shares of Genzyme for $69 per share.

5 Oct 2010

Medical News

Archimedes publishes FPNS clinical study results in Pain journal

IRIDEX announces commercial availability of extended EndoProbe laser delivery device family in Japan

HighPoint Solutions launches ICD-10 Appliance for healthcare systems

Preclinical data of Enzon's PEG-SN38 in pediatric neuroblastoma published in Clinical Cancer Research

Caring.com introduces interactive Alzheimer’s resource for caregivers

Majority of Canadians with asthma consider their disease 'well controlled'

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

Intellect Neurosciences receives patent for Alzheimer's disease monoclonal antibody program

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

ImmunoCellular Therapeutics to present ICT-107 clinical data at World Stem Cell Summit

GE Healthcare launches first human cellular assay product

SpinalMotion announces completion of enrollment in Kineflex lumbar artificial disc study

Celgene announces pricing of senior unsecured notes

Medyssey Spine fourth-quarter 2010 sales increase 112%

EUCODIS Bioscience, evocatal enter alliance to market industrial enzyme products

Ceremed's implantable polymer material receives Best New Technology for Spine Care award

FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA

Dr. Bessler joins Children's Hospital of Philadelphia

First Edition: October 5, 2010

Genzyme shareholders urged not to take action on unsolicited tender offer from Sanofi-Aventis

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News